AEGON ASSET MANAGEMENT UK Plc Decreases Holdings in Colgate-Palmolive (NYSE:CL)

AEGON ASSET MANAGEMENT UK Plc trimmed its stake in Colgate-Palmolive (NYSE:CLFree Report) by 11.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,036,460 shares of the company’s stock after selling 128,644 shares during the quarter. Colgate-Palmolive makes up 1.2% of AEGON ASSET MANAGEMENT UK Plc’s holdings, making the stock its 16th biggest position. AEGON ASSET MANAGEMENT UK Plc owned approximately 0.13% of Colgate-Palmolive worth $94,244,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth about $1,315,000. Gordian Advisors LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors grew its stake in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after buying an additional 7,353 shares in the last quarter. Fiduciary Alliance LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $4,066,000. Finally, Vontobel Holding Ltd. lifted its position in shares of Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 0.0 %

Shares of NYSE CL opened at $87.88 on Friday. The stock has a market capitalization of $71.79 billion, a P/E ratio of 25.18, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a one year low of $80.03 and a one year high of $109.30. The firm’s 50 day simple moving average is $91.81 and its two-hundred day simple moving average is $97.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.34% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CL. Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Finally, TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.11.

Get Our Latest Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.